Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
11/15/2004
 
First Published:
1/1/1998
1.
Phase II Study of Lutetium Texaphyrin (PCI-0123) in Photodynamic Therapy for Locally Recurrent Breast Cancer That Failed Prior Radiation Therapy (Summary Last Modified 06/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
PCI-P125-9702
NCI-V97-1314
Last Modified:
11/15/2004
 
First Published:
4/1/1998
2.
Phase II Study of Lutetium Texaphyrin Injection Prior to Phototherapy and with Concurrent Hormonal Therapy for Recurrent or Metastatic Breast Cancer (Summary Last Modified 01/99)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
Pharmaceutical / Industry
PCI-P125-9701
NCI-V97-1315
Last Modified:
11/15/2004
3.
Phase I Study of Photodynamic Therapy with Lutetium Texaphyrin (PCI-0123) for Malignancies Accessible to Laser Illumination (Summary Last Modified 09/96)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
Pharmaceutical / Industry
PCI-P123-9501
NCI-V96-0843
Last Modified:
12/10/2008
 
First Published:
4/1/2000
4.
Phase I Study of Photodynamic Therapy With Lutetium Texaphyrin in Patients With Locally Recurrent Prostate Adenocarcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
UPCC-6899
NCI-T99-0042, NCT00005067, T99-0042
Last Modified:
9/5/2008
 
First Published:
6/1/2000
5.
Phase I Study of Photodynamic Therapy With Lutetium Texaphyrin in Patients With Grade II or III Cervical Intraepithelial Neoplasia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Prevention
Completed
18 to 65
NCI
PCI-07931
NCI-T98-0066, NCT00005808, T98-0066, PCI-01-081
Last Modified:
4/20/2007
 
First Published:
6/23/2004
6.
Diagnostic Study of the Distribution of EF5 for the Detection of Tumor Hypoxia and Motexafin Lutetium in Patients With Intra-Abdominal Malignancies or Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Completed
18 and over
NCI
UPCC-04204
NCI-6508, 6508, NCT00087191
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute